https://www.selleckchem.com/pr....oducts/alofanib-rpt8
1%) than in controls (8.8%). The proportions of levofloxacin and metronidazole resistance were greater in cases than in controls (P0.05). Among cases treated with H.pylori triple therapy (S3T), the 'optimal' subgroup experienced a 9.5% failure rate vs. 28.6% with other strategies (P=0.01). Risk factors for failure were H.pylori treatment strategy, exposure to antiretroviral treatment, and alcohol status. Overall, positive HIV status was a risk factor for S3T eradication failure. Patients co-infected with H. pylori and HIV fr
Curtir
Comentario
Compartilhar
